Your browser doesn't support javascript.
loading
Brief Report: Efficacy and Safety of Oral Islatravir Once Daily in Combination With Doravirine Through 96 Weeks for Treatment-Naive Adults With HIV-1 Infection Receiving Initial Treatment With Islatravir, Doravirine, and Lamivudine.
Molina, Jean-Michel; Yazdanpanah, Yazdan; Afani Saud, Alejandro; Bettacchi, Christopher; Chahin Anania, Carolina; Klopfer, Stephanie O; Grandhi, Anjana; Eves, Karen; Hepler, Deborah; Robertson, Michael N; Hwang, Carey; Hanna, George J; Correll, Todd.
Afiliação
  • Molina JM; Department of Infectious Diseases, St-Louis and Lariboisière Hospitals, APHP, University of Paris, INSERM U944.
  • Yazdanpanah Y; Department of Infectious Diseases, Bichat Claude Barnard Hospital, APHP, University of Paris, Inserm U1137.
  • Afani Saud A; Department of Infectious Diseases, University of Chile, Santiago, Chile.
  • Bettacchi C; HIV Center, North Texas Infectious Diseases Consultants, Dallas, TX.
  • Chahin Anania C; Department of Infectious Diseases, Hospital Hernán Henríquez Aravena of Temuco, Temuco, Chile; and.
  • Klopfer SO; Merck & Co., Inc., Rahway, NJ.
  • Grandhi A; Merck & Co., Inc., Rahway, NJ.
  • Eves K; Merck & Co., Inc., Rahway, NJ.
  • Hepler D; Merck & Co., Inc., Rahway, NJ.
  • Robertson MN; Merck & Co., Inc., Rahway, NJ.
  • Hwang C; Merck & Co., Inc., Rahway, NJ.
  • Hanna GJ; Merck & Co., Inc., Rahway, NJ.
  • Correll T; Merck & Co., Inc., Rahway, NJ.
J Acquir Immune Defic Syndr ; 91(1): 68-72, 2022 09 01.
Article em En | MEDLINE | ID: mdl-35972855

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Desoxiadenosinas / HIV-1 Tipo de estudo: Clinical_trials / Guideline Limite: Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Desoxiadenosinas / HIV-1 Tipo de estudo: Clinical_trials / Guideline Limite: Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article